2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Adana A.M. Llanos, PhD, MPH, discusses disparities in genetic research in cancer care.
Adana A.M. Llanos, PhD, MPH, cancer and molecular epidemiologist, Mailman School of Public Health, Columbia University, adjunct associate professor, Rutgers School of Public Health, discusses disparities in genetic research in cancer care.
When considering emerging data and ongoing studies evaluating the genetics of patients with cancer, such as triple-negative breast cancer (TNBC), limitations still exist regarding this research, Llanos says. Racial and ethnic minority groups, specifically those of African ancestry, have been underrepresented in prior research into the genetics of cancer, Llanos explains.
Broad representation in new and future studies will be critical, Llanos adds. Expanding research to provide a more inclusive look at genetic and etiological differences in patients will provide a clearer picture as to how they can affect treatment, Llanos concludes.